 Well, we've developed a unique approach for the delivery of therapeutic drugs. We have an integrated solution that combines four separate technologies. The first is smart drug delivery, delivering the drug so it's time to the patient's symptoms to have the optimum benefit. The second is compliance measurement. Compliance is a major problem in drugs today, and with our technology we can measure whether they're actually taking the drug and then providing encouragement and reinforcement to make sure that they do take their drug. The third is behavioral support, helping them deal and work through the issues associated with their disease or disorder. And the final one is data analytics, accumulating data so we can continuously improve the therapy and then share this that information with patients, with providers, and with payers. I think our key is that we've hired extremely talented, extremely experienced group of individuals from a variety of different disciplines. From technology, from behavioral support, industrial design, drug development, and putting them all together, they can look at problems in a unique way and come up with unique solutions. Well, our first application is smoking cessation. And smoking is the number one preventable cause of death in the world today, responsible for more than six million deaths each year. And we believe our unique product can have a significant impact on health care both in the United States, in Europe, and the rest of the world.